Percutaneous CT-guided biopsy of lytic bone lesions in patients clinically suspected of lung cancer: Diagnostic performances for pathological diagnosis and molecular testing

Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste et al. · New England Journal of Medicine · 2017 · 5.3K citations · Full text

Medicine, Oncology, Pharmacology +16

Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Solange Peters, D. Ross Camidge, Alice T. Shaw et al. · New England Journal of Medicine · 2017 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +16

Society of Interventional Radiology Clinical Practice Guidelines

David Sacks, Tricia E. McClenny, John F. Cardella et al. · Journal of Vascular and Interventional Radiology · 2003 · 1.7K citations · Full text

Medicine, Radiology, Diagnostic Imaging +9

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio et al. · The Lancet · 2016 · 984 citations

Medicine, Molecular Medicine, Oncology +11

The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*

HENRY J. MANKIN, Carole J. Mankin, Michael A. Simon · Journal of Bone and Joint Surgery · 1996 · 772 citations

Medicine, Oncology, Surgery +15